Projects

Development and Validation of a Novel, Third-Generation Lifestyle (Exercise and Nutrition) Prescription for Precision Medicine in Indians with cardiometabolic diseases (DEVELOP Study).

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - 2025

Project Lead

Pranathi R

Authors

Pranathi R, Denis Xavier, Rebecca Kuriyan Raj, Tony Raj, Ganapathi Bantwal, Ambily Sivadas

Project Status

ongoing

Project Type

RCT (ICMR Small Assistance grant)